MedTrace Logo

Procalcitonin Level as a Surrogate for Catheter-related Blood Stream Bacteremia Among Hemodialysis Patients

NCT03039777 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 28

Last updated 2017-07-17

No results posted yet for this study

Summary

Hemodialysis patients frequently develop catheter-related blood stream bacteremia (CRBSI). Procalcitonin is a marker of sepsis in bacterial infection. this study for detection of its role as a surrogacy marker in CRBSI.

Conditions

  • Hemodialysis Catheter Infection

Sponsors & Collaborators

  • New Jeddah Clinic Hospital

    collaborator INDUSTRY

  • Benha University

    lead OTHER

Principal Investigators

  • Mahmoud H Imam, MD · Benha University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-01
Primary Completion
2017-02-28
Completion
2017-03-01

Countries

  • Saudi Arabia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03039777 on ClinicalTrials.gov